Chronic Pulmonary Diseases and COVID-19
PDF
Cite
Share
Request
Review
VOLUME: 21 ISSUE: 5
P: 345 - 349
September 2020

Chronic Pulmonary Diseases and COVID-19

Turk Thorac J 2020;21(5):345-349
1. Department of Pulmonary Medicine, Trakya University School of Medicine, Edirne, Turkey
No information available.
No information available
Accepted Date: 30.09.2020
Online Date: 30.09.2020
Publish Date: 30.09.2020
PDF
Cite
Share
Request

Abstract

Over the past few months, coronavirus disease 2019 (COVID-19) has assumed the character of a pandemic, leading to significant global mortality mostly because of COVID-19–related pneumonia. Pneumonia is likely to progress more severely in patients with underlying chronic lung disease. The purpose of this review is to discuss the management strategies in patients with chronic lung disease such as chronic obstructive pulmonary disease, asthma, pleural diseases, and obstructive sleep apnea during the COVID-19 pandemic, with current literatures and international guidelines.

Cite this article as:

Çakır Edis E. Chronic pulmonary diseases and  COVID-19. Turk Thorac J 2020; 21(5): 345-9.

Keywords:
Chronic pulmonary disease, coronavirus disease 2019, management